Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617000713392
Ethics application status
Approved
Date submitted
9/05/2017
Date registered
17/05/2017
Date last updated
17/05/2017
Type of registration
Prospectively registered
Titles & IDs
Public title
Metabolic effects of consuming carbonated water or kiwifruit on a daily basis over seven-weeks
Query!
Scientific title
The effect on healthy adults of consuming a kiwifruit preload on glucose and lipid metabolism
Query!
Secondary ID [1]
291898
0
nil
Query!
Universal Trial Number (UTN)
U1111-1196-3977
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Hyperinsulinaemia
303190
0
Query!
Hyperglycaemia
303191
0
Query!
Blood lipids
303192
0
Query!
Condition category
Condition code
Diet and Nutrition
302629
302629
0
0
Query!
Other diet and nutrition disorders
Query!
Metabolic and Endocrine
302717
302717
0
0
Query!
Normal metabolism and endocrine development and function
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This will be a parallel randomized trial of two groups over seven-weeks. One group will consume two gold kiwifruit and 500mL carbonated water as a preload to breakfast each day (consumed within the 30 minutes leading up to breakfast). Prior to the intervention, participants’ normal breakfasts will be characterized by asking them to fill in weighed breakfast records for 7 days. The intervention will involve reducing breakfast by an amount equivalent to the carbohydrate contained in the gold kiwifruit preload. For example, if a person ate two slices of jam on toast for breakfast, one of those slices would be replaced by gold kiwifruit. This strategy may produce measurable benefit to metabolic markers over seven weeks; sufficient time for changes in lipids and glycaemic markers to occur. We will obtain breakfast records and train people how to substitute part of their breakfast with the gold kiwifruit. If the habitual breakfast contains fat, this will be removed propotionately with amount of CHO that is substituted with gold kiwifruit, providing a mechanism by which blood lipids would be affected. To monitor adherence we will record kiwifruit/carbonated water collection visits and obtain diet records during the intervention period. This intervention will be conducted by a postgraduate student with a Master of Science in Human Nutrition as part of her PhD with supervision by senior university and Crown Research Institute staff.
Query!
Intervention code [1]
298013
0
Lifestyle
Query!
Comparator / control treatment
The comparison group will consume 500 mL carbonated water as a preload to their habitual breakfast each day (consumed within the 30 minutes leading up to breakfast) to encourage compliance, while water is unlikely to have an effect on lipids and glucose.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
302039
0
Between group difference in fasting plasma insulin concentration, adjusted for baseline, using blood obtained via venipuncture at visits 1, 2, 5, and 6. Plasma insulin will be analysed using a Roche Elecsys electrochemiluminescence immunoanalyser
Query!
Assessment method [1]
302039
0
Query!
Timepoint [1]
302039
0
From 0 to 7 weeks
Query!
Primary outcome [2]
302040
0
Between group difference in fasting blood glucose concentration, adjusted for baseline, using blood obtained via capillary at visits 1, 2, 5, and 6. Blood glucose will be measured using a Hemocue instrument.
Query!
Assessment method [2]
302040
0
Query!
Timepoint [2]
302040
0
From 0 to 7 weeks
Query!
Secondary outcome [1]
334603
0
Change in plasma total cholesterol
Query!
Assessment method [1]
334603
0
Query!
Timepoint [1]
334603
0
From 0 to 7 weeks
Query!
Secondary outcome [2]
334604
0
Change in plasma triglycerides
Query!
Assessment method [2]
334604
0
Query!
Timepoint [2]
334604
0
From 0 to 7 weeks
Query!
Secondary outcome [3]
334605
0
Change in plasma uric acid
Query!
Assessment method [3]
334605
0
Query!
Timepoint [3]
334605
0
From 0 to 7 weeks
Query!
Secondary outcome [4]
334606
0
Change in plasma metabolomics
Query!
Assessment method [4]
334606
0
Query!
Timepoint [4]
334606
0
From 0 to 7 weeks
Query!
Eligibility
Key inclusion criteria
Healthy adults
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
fasting glucose level above the normal range (>6.0mmol/L)
a BMI >30kg/m2
have had gastrointestinal surgical procedures
have a known allergy to kiwifruit
females who are pregnant
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
A biostatistician will randomise treatments and place these in sealed envelopes. Each time a new participant presents, the investigator will take the next envelope and open it to reveal the group allocation.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
A total of 40 participants (20 per group) would be required to detect a clinically meaningful difference of 1 standard deviation in plasma glucose and insulin concentration with 80% power and a significance level of 0.05
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
23/05/2017
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
27/06/2017
Query!
Actual
Query!
Date of last data collection
Anticipated
29/09/2017
Query!
Actual
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
8890
0
New Zealand
Query!
State/province [1]
8890
0
Otago
Query!
Funding & Sponsors
Funding source category [1]
296400
0
Government body
Query!
Name [1]
296400
0
High Value Nutrition
Query!
Address [1]
296400
0
Liggins Institute
The University of Auckland
Private Bag 92019
Victoria Street West
Auckland 1142
New Zealand
Query!
Country [1]
296400
0
New Zealand
Query!
Primary sponsor type
Government body
Query!
Name
Plant & Food Research Limited
Query!
Address
Food Industry Science Centre
Fitzherbert Science Centre
Batchelar Road
Palmerston North 4474
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
295341
0
University
Query!
Name [1]
295341
0
University of Otago
Query!
Address [1]
295341
0
Department of Human Nutrition
PO Box 56
Dunedin 9054
Query!
Country [1]
295341
0
New Zealand
Query!
Secondary sponsor category [2]
295343
0
Commercial sector/Industry
Query!
Name [2]
295343
0
Zespri International Ltd
Query!
Address [2]
295343
0
PO Box 4043
Mount Maunganui South
400 Maunganui Road
Mount Maunganui 3116
New Zealand
Query!
Country [2]
295343
0
New Zealand
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
297629
0
University of Otago Human Ethics Committee (Health)
Query!
Ethics committee address [1]
297629
0
Human Ethics Committee PO Box 56 Dunedin 9054
Query!
Ethics committee country [1]
297629
0
New Zealand
Query!
Date submitted for ethics approval [1]
297629
0
10/04/2017
Query!
Approval date [1]
297629
0
23/04/2017
Query!
Ethics approval number [1]
297629
0
H17/048
Query!
Summary
Brief summary
Kiwifruit preloads to breakfast have been found to acutely modify the postprandial blood glucose response compared with a non-preload condition. Our aim is to test whether there is a longer-term effect of kiwifruit preload on metabolic markers over 7-weeks. The intervention group will consume 2 kiwifruit and a 500mL bottle of carbonated water 30 min prior to the remainder of breakfast whilst the control group will consume carbonated water in the 30min prior to breakfast. Main outcomes will be differences in fasting plasma glucose and insulin between groups adjusted for baseline. Secondary outcomes will be differences in fasting lipids and uric acid between groups adjusted for baseline.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
74646
0
Dr Bernard Venn
Query!
Address
74646
0
Department of Human Nutrition
University of Otago
PO Box 56
Dunedin
9054
Query!
Country
74646
0
New Zealand
Query!
Phone
74646
0
+6434795068
Query!
Fax
74646
0
Query!
Email
74646
0
[email protected]
Query!
Contact person for public queries
Name
74647
0
John Monro
Query!
Address
74647
0
Food Industry Science Centre
Fitzherbert Science Centre
Batchelar Road
Palmerston North
4474
Query!
Country
74647
0
New Zealand
Query!
Phone
74647
0
+646953 7700
Query!
Fax
74647
0
Query!
Email
74647
0
[email protected]
Query!
Contact person for scientific queries
Name
74648
0
John Monro
Query!
Address
74648
0
Food Industry Science Centre
Fitzherbert Science Centre
Batchelar Road
Palmerston North
4474
Query!
Country
74648
0
New Zealand
Query!
Phone
74648
0
+646953 7700
Query!
Fax
74648
0
Query!
Email
74648
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
Type
Is Peer Reviewed?
DOI
Citations or Other Details
Attachment
Basic results
No
372897-(Uploaded-21-04-2021-06-42-09)-Basic results summary.xlsx
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Metabolic and Blood Pressure Effects of Consuming Two Kiwifruit Daily for 7 Weeks: A Randomised Controlled Trial.
2022
https://dx.doi.org/10.3390/nu14132678
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF